Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia

被引：167

作者：

Tausch, Eugen ^{[1
]}

Close, William ^{[1
]}

Dolnik, Anna ^{[2
]}

Bloehdorn, Johannes ^{[1
]}

Chyla, Brenda ^{[3
]}

Bullinger, Lars ^{[2
]}

Doehner, Hartmut ^{[1
]}

Mertens, Daniel ^{[1
,4
]}

Stilgenbauer, Stephan ^{[1
,5
]}

机构：

[1] Ulm Univ, Dept Internal Med 3, Ulm, Germany

[2] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[3] AbbVie, N Chicago, IL USA

[4] Deutsch Krebsforschungszentrum DKFZ, Cooperat Unit Mech Leukemogenesis, Heidelberg, Germany

[5] Saarland Univ, Sch Med, Dept Hematol Oncol & Rheumatol, Homburg, Germany

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 09期

关键词：

ABT-199;

D O I：

10.3324/haematol.2019.222588

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 10 条

[1]

[Anonymous], 2018, SCHROD REL 2018 4 MA

[2] Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia [J].

Blombery, Piers ;

Anderson, Mary Ann ;

Gong, Jia-nan ;

Thijssen, Rachel ;

Birkinshaw, Richard W. ;

Thompson, Ella R. ;

Teh, Charis E. ;

Nguyen, Tamia ;

Xu, Zhen ;

Flensburg, Christoffer ;

Lew, Thomas E. ;

Majewski, Ian J. ;

Gray, Daniel H. D. ;

Westerman, David A. ;

Tam, Constantine S. ;

Seymour, John F. ;

Czabotar, Peter E. ;

Huang, David C. S. ;

Roberts, Andrew W. .

CANCER DISCOVERY, 2019, 9 (03) :342-353

[3] Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma [J].

Fresquet, Vicente ;

Rieger, Melissa ;

Carolis, Carlo ;

Garcia-Barchino, Maria J. ;

Martinez-Climent, Jose A. .

BLOOD, 2014, 123 (26) :4111-4119

[4] Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study [J].

Kater, Arnon P. ;

Seymour, John F. ;

Hillmen, Peter ;

Eichhorst, Barbara ;

Langerak, Anton W. ;

Owen, Carolyn ;

Verdugo, Maria ;

Wu, Jenny ;

Punnoose, Elizabeth A. ;

Jiang, Yanwen ;

Wang, Jue ;

Boyer, Michelle ;

Humphrey, Kathryn ;

Mobasher, Mehrdad ;

Kipps, Thomas J. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) :269-+

[5] UCSF chimera - A visualization system for exploratory research and analysis [J].

Pettersen, EF ;

Goddard, TD ;

Huang, CC ;

Couch, GS ;

Greenblatt, DM ;

Meng, EC ;

Ferrin, TE .

JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) :1605-1612

[6] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia [J].

Roberts, Andrew W. ;

Davids, Matthew S. ;

Pagel, John M. ;

Kahl, Brad S. ;

Puvvada, Soham D. ;

Gerecitano, John F. ;

Kipps, Thomas J. ;

Anderson, Mary Ann ;

Brown, Jennifer R. ;

Gressick, Lori ;

Wong, Shekman ;

Dunbar, Martin ;

Zhu, Ming ;

Desai, Monali B. ;

Cerri, Elisa ;

Enschede, Sari Heitner ;

Humerickhouse, Rod A. ;

Wierda, William G. ;

Seymour, John F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) :311-322

[7] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia [J].

Seymour, J. F. ;

Kipps, T. J. ;

Eichhorst, B. ;

Hillmen, P. ;

D'Rozario, J. ;

Assouline, S. ;

Owen, C. ;

Gerecitano, J. ;

Robak, T. ;

De la Serna, J. ;

Jaeger, U. ;

Cartron, G. ;

Montillo, M. ;

Humerickhouse, R. ;

Punnoose, E. A. ;

Li, Y. ;

Boyer, M. ;

Humphrey, K. ;

Mobasher, M. ;

Kater, A. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) :1107-1120

[8] ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets [J].

Souers, Andrew J. ;

Leverson, Joel D. ;

Boghaert, Erwin R. ;

Ackler, Scott L. ;

Catron, Nathaniel D. ;

Chen, Jun ;

Dayton, Brian D. ;

Ding, Hong ;

Enschede, Sari H. ;

Fairbrother, Wayne J. ;

Huang, David C. S. ;

Hymowitz, Sarah G. ;

Jin, Sha ;

Khaw, Seong Lin ;

Kovar, Peter J. ;

Lam, Lloyd T. ;

Lee, Jackie ;

Maecker, Heather L. ;

Marsh, Kennan C. ;

Mason, Kylie D. ;

Mitten, Michael J. ;

Nimmer, Paul M. ;

Oleksijew, Anatol ;

Park, Chang H. ;

Park, Cheol-Min ;

Phillips, Darren C. ;

Roberts, Andrew W. ;

Sampath, Deepak ;

Seymour, John F. ;

Smith, Morey L. ;

Sullivan, Gerard M. ;

Tahir, Stephen K. ;

Tse, Chris ;

Wendt, Michael D. ;

Xiao, Yu ;

Xue, John C. ;

Zhang, Haichao ;

Humerickhouse, Rod A. ;

Rosenberg, Saul H. ;

Elmore, Steven W. .

NATURE MEDICINE, 2013, 19 (02) :202-208

[9] Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial [J].

Stilgenbauer, Stephan ;

Eichhorst, Barbara ;

Schetelig, Johannes ;

Hillmen, Peter ;

Seymour, John F. ;

Coutre, Steven ;

Jurczak, Wojciech ;

Mulligan, Stephen P. ;

Schuh, Anna ;

Assouline, Sarit ;

Wendtner, Clemens-Martin ;

Roberts, Andrew W. ;

Davids, Matthew S. ;

Bloehdorn, Johannes ;

Munir, Talha ;

Boettcher, Sebastian ;

Zhou, Lang ;

Salem, Ahmed Hamed ;

Desai, Monali ;

Chyla, Brenda ;

Arzt, Jennifer ;

Kim, Su Young ;

Verdugo, Maria ;

Gordon, Gary ;

Hallek, Michael ;

Wierda, William G. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) :1973-+

[10] Potential mechanisms of resistance to venetoclax and strategies to circumvent it [J].

Tahir, Stephen K. ;

Smith, Morey L. ;

Hessler, Paul ;

Rapp, Lisa Roberts ;

Idler, Kenneth B. ;

Park, Chang H. ;

Leverson, Joel D. ;

Lam, Lloyd T. .

BMC CANCER, 2017, 17

← 1 →